enter here
Open Label Multi-Site Study of Safety and Effects of MDMA-assisted Psychotherapy for Treatment of PTSD With Optional fMRI Sub-Study
About the study
NCT Trial Number
NCT04030169
The drug being studied
MDMA
Sponsored by
MAPS Europe B.V.
Multidisciplinary Association for Psychedelic Studies
Trial Start Date
Jun-20
About the participants
Age seeking
18 Years and older
gender
All
Primary condition of volunteers accepted
PTSD (Post Traumatic Stress Disorder)
Accepts healthy volunteers?
No
This study explores the safety and effectiveness of MDMA-assisted psychotherapy as a treatment for PTSD
Locations
Czechia
NUDZ - National Institute of Mental Health
Klecany, Středočeský Kraj, Czechia, 250 67
Contact: Michaela Victorinova
+420283088258
michaela.viktorinova@nudz.cz
Netherlands
Maastricht University, Dept of Neuropsychology and Psychopharmacology Not yet recruiting
Maastricht, Limburg, Netherlands, 6229 ER
Contact: Kim Kuypers
+31433881902
k.kuypers@maastrichtuniversity.nl
Stichting Centrum '45/Arq
Oegstgeest, Noord Holand, Netherlands, 2342 AX
Contact:
Viyan Bedawi
+31715191500
V.Bedawi@centrum45.nl
Norway
Sykehuset Østfold Hf, DPS Norder
Moss, Norway, 1535
Contact: Study Team General
+47 69 86 97 61
psykforsk@so-hf.no
Portugal
Fundação de Anna de Sommer Champalimaud
Lisbon, Portugal, 1400-038
United Kingdom
University Hospital of Wales - Research Facility
Cardiff, United Kingdom, CF14 4XW
Contact: Mathew Hoskins
hoskinsmd1@cardiff.ac.uk